MayaRae N Mugosa; Jefferson W Kinney; Lorenzo Gabriel Pasia; Mason Jonah; Isabella Hou; Aaron Ritter · 2025 · Alzheimer's & Dementia
Paper
Abstract Background Alzheimer's disease (AD) is a progressive neurodegenerative disease affecting memory and cognitive processes, making it increasingly difficult for individuals to perform daily tasks as the disease progresses. Early diagnosis and tracking of disease progression is crucial for optimal treatment and support. Current diagnostic methods for AD include positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), evaluation of cerebrospinal fluid (CSF) and other invasive and expensive tools. Blood biomarkers provide more cost‐effective and scalable assessment and disease progression. Methods We have previously evaluated human plasma concentrations of glial fibrillary acidic protein (GFAP) and phosphorylated tau‐181 (ptTau181) using the single molecular array (SIMOA) Quanterix instrument. Using chemiluminescent enzyme immunoassay (CLEIA) technology on the Lumipulse G1200 platform, we evaluated concentrations in human plasma for phosphorylated tau‐217 (pTau217). Protocols for each corresponding protein kit were followed without modification. Results Concentrations of these proteins were analyzed for differences between disease states over a two year difference to identify potential significant disease progression. Despite having no statistical significance, the longitudinal analysis suggests a consistent trend over time, with a gradual increase in target concentrations of some candidate biomarkers. Conclusions The longitudinal analysis revealed intriguing trends that warrant further investigation with a larger sample size. Continued pursuit of pTau217 would be beneficial, given its strong correlation with amyloid status, which suggests potential as a valuable biomarker for AD disease progression.
Analysis
Preparing paper insights from the available abstract and paper details.
Discovery
Sharyn L. Rossi; Diane E. Bovenkamp
Nicholas Reed; James Pike; Jennifer Deal; Priya Palta; Josef Coresh
Natascha Merten; Josef Coresh; Bryan James
Dietmar Rudolf Thal; Koen Poesen; Rik Vandenberghe; Steffi De Meyer
Nicholas J. Ashton; Wagner S. Brum; Guglielmo Di Molfetta; Andréa Lessa Benedet; Burak Arslan; Erin M. Jonaitis; Rebecca E. Langhough; Karly Alex Cody; Rachael E. Wilson; Cynthia M. Carlsson; Eugeen Vanmechelen; Laia Montoliu‐Gaya; Juan Lantero‐Rodriguez; Nesrine Rahmouni; Cécile Tissot; Jenna Stevenson; Stijn Servaes; Joseph Therriault; Tharick A. Pascoal; Alberto Lleó; Daniel Alcolea; Juan Fortea; Pedro Rosa‐Neto; Sterling C. Johnson; Andreas Jeromin; Kaj Blennow; Henrik Zetterberg
Richard Novobilský; Petra Bartova; Karin Lichá; Michal Bar; David Stejskal; Pavlína Kusnierova
Source record